NEW YORK, May 15, 2017 /PRNewswire/ --

Anadarko Petroleum Corporation (APC)

Lifshitz & Miller announces investigation on behalf of APC investors concerning whether APC failed to maintain adequate safety protocols in connection with certain of its vertical wells, leading to an increased risk of an explosion.

If you are an APC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

DryShips Inc. (DRYS)

Lifshitz & Miller announces investigation on behalf of DRYS investors concerning whether DRYS issued false and misleading statements about its business, operations and prospects causing its share price to peak at soar between November 9 and November 16, 2016 from $163 to $2,336 per share. After DRYS' price peaked, DRYS engaged in a series of stock sales totaling more than $500 million and shares have fallen over 99% in price.

If you are an DRYS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ImmunoCellular Therapeutics, Ltd. (IMUC)

Lifshitz & Miller announces investigation on behalf of IMUC investors concerning whether IMUC engaged in an illegal stock promotion scheme by paying for Lidingo Holdings, LLC to publish positive articles promoting IMUC's clinical studies of ICT-107.

If you are an IMUC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

KBR, Inc. (KBR)

Lifshitz & Miller announces investigation on behalf of KBR investors concerning whether a KBR subsidiary violated applicable bribery and corruption laws in the United Kingdom.

If you are a KBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Sunesis Pharmaceuticals, Inc. (SNSS)

Lifshitz & Miller announces investigation on behalf of SNSS investors concerning whether SNSS failed to adequately disclose the suitability of its treatment vosaroxin for approval in Europe.

If you are an SNSS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Sunrun Inc. (RUN)

Lifshitz & Miller announces investigation on behalf of RUN investors concerning whether RUN failed to accurately disclose how many customers cancelled contracts after signing up for RUN's home-solar energy system.

If you are a RUN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Vince Holding Corp. (VNCE)

Lifshitz & Miller announces investigation on behalf of VNCE investors concerning whether VNCE failed to disclose it experienced issues related to integrating its new enterprise resource planning systems.

If you are a VNCE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq. 
Lifshitz & Miller LLP
Phone:  516-493-9780  
Facsimile: 516-280-7376 
Email: [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-anadarko-petroleum-corporation-dryships-inc-immunocellular-therapeutics-ltd-kbr-inc-sunesis-pharmaceuticals-inc-sunrun-inc-and-vince-holding-corp-300457983.html

SOURCE Lifshitz & Miller Law Firm